Supported by a team of world-class scientists and experts in the field.
Santiago Matheus
Founder & Managing Partner
Santiago Matheus
Founder & Managing Partner
“As a sci-fi nerd, I am fascinated by the possibilities inherent in turning frontier technologies into a secure, healthy and sustainable future.”
Former partner at IBM Strategy and managing director at IDEO and Method Design. Angel investor in UK deep tech, including Uncommon Bio and PureLiFi.
Co-Founded Steam Capital, Method Design Lab (a JV with UCL) and the Founder’s Bank Project.
MBA, INSEAD.
“As a sci-fi nerd, I am fascinated by the possibilities inherent in turning frontier technologies into a secure, healthy and sustainable future.”
Andres Bluhm
Founder & Investment Committee
Andres Bluhm
Founder & Investment Committee
“I am excited by ideas that unlock long-lasting value beyond a single product. I love working with visionary founders who have invented entirely new ways to do things and helping them navigate through their business and operational challenges to achieve their objectives.”
Serial deep tech investor, including first rounds at Uncommon Bio, Opteran, Baseimmune, Cogitat and Inoviv.
Formerly with Creator Fund, Northern Power Systems, Andersen Consulting.
Sloan Fellow, London Business School.
“I am excited by ideas that unlock long-lasting value beyond a single product. I love working with visionary founders who have invented entirely new ways to do things and helping them navigate through their business and operational challenges to achieve their objectives.”
Andrew Cavaghan
Founder & Investment Committee Chair
Andrew Cavaghan
Founder & Investment Committee Chair
“In a world full of hype, I strive to find the truth. I believe in always asking the difficult questions so that we can cut through to what’s real, what’s possible, and how we can achieve it.”
Original team member at Octopus Investments and London Seed Capital.
Co-founder and CEO of Blue Gold, (Nasdaq: BGL), that aspires to be the world’s first digital gold company.
Barrister-at-Law, UK.
“In a world full of hype, I strive to find the truth. I believe in always asking the difficult questions so that we can cut through to what’s real, what’s possible, and how we can achieve it.”
Oliver Owens
Investment Manager
Oliver Owens
Investment Manager
“I’m passionate about discovering and backing transformational technologies that will disrupt industries and shape our future. DeepTech enables us to tackle the world’s hardest problems at their source – where real, lasting impact begins.”
Investment professional with a focus on early-stage climate and deep tech.
Former investment executive at Green Angel Ventures.
Business Economics Bsc. (Entrepreneurship), University of Exeter.
“I’m passionate about discovering and backing transformational technologies that will disrupt industries and shape our future. DeepTech enables us to tackle the world’s hardest problems at their source – where real, lasting impact begins.”
Adam Phillips
Biotech Lead
Adam Phillips
Biotech Lead
“What excites me most is the potential for science and technology to solve problems at their root — my passion lies in helping those breakthroughs become reality.”
MD candidate 2027, University of East Anglia.
Former strategy consultant at IBM.
Post-graduate researcher, University of Oxford (stem cell modelling).
MBioSci, Southampton.
“What excites me most is the potential for science and technology to solve problems at their root — my passion lies in helping those breakthroughs become reality.”
Mark Van Der Wilk
AI Lead
Mark Van Der Wilk
AI Lead
“While my day job is now in machine learning, I have always been fascinated by understanding how things work in any field of science I encounter. I relish the opportunity to have in-depth discussions about how tomorrow’s tech works with those who are building it today.”
Associate Professor in Computer Sciences, Oxford.
Formerly senior lecturer, Imperial College.
Formerly with Secondmind, Google ATAP.
PhD Machine Learning, Cambridge.
“While my day job is now in machine learning, I have always been fascinated by understanding how things work in any field of science I encounter. I relish the opportunity to have in-depth discussions about how tomorrow’s tech works with those who are building it today.”
Alessandra Sabatini
BioTech Venture Fellow
Alessandra Sabatini
BioTech Venture Fellow
“I’m driven by the potential of engineering biology to redefine the biotech landscape and create breakthrough technologies. I am excited to work alongside companies that are pushing the boundaries of science with novel approaches and bold ideas.”
PhD Biomolecular Engineering, University of Sheffield.
BSc Biology, University of Manchester.
Ex AstraZeneca Associate Scientist, Illumina Inc. Development scientist.
“I’m driven by the potential of engineering biology to redefine the biotech landscape and create breakthrough technologies. I am excited to work alongside companies that are pushing the boundaries of science with novel approaches and bold ideas.”
Diana Drago Garcia
TechBio Venture Fellow
Diana Drago Garcia
TechBio Venture Fellow
“What excites me most is the potential of deeptech to turn scientific breakthroughs into real-world impact, especially in healthcare. I’m driven by the possibility of translating complex biology into technologies that can radically improve lives!”
Postdoctoral fellow at the Stem Cell and Cancer Biology Laboratory, at the Francis Crick Institute in London, UK.
PhD Weizmann Institute of Science, Department of Immunology and Regenerative Biology, Israel.
Masters National Institute of Genomic Medicine, Mexico.
“What excites me most is the potential of deeptech to turn scientific breakthroughs into real-world impact, especially in healthcare. I’m driven by the possibility of translating complex biology into technologies that can radically improve lives!”
Edzus Nakmus
Physics / Quantum Venture Fellow
Edzus Nakmus
Physics / Quantum Venture Fellow
“I’m driven by the challenge of separating hype from reality in emerging science. There’s nothing more rewarding than digging into complex systems and finding out what really works.”
MSc Quantum Fields & Fundamental Forces, Imperial College.
BSc Theoretical Physics, University College Dublin.
Former researcher at Dublin Institute for Advanced Studies.
“I’m driven by the challenge of separating hype from reality in emerging science. There’s nothing more rewarding than digging into complex systems and finding out what really works.”
Selina Tsai
BioTech Venture Fellow
Selina Tsai
BioTech Venture Fellow
“I’m driven by the ambition to turn cutting-edge science into real-world treatments—building new therapeutics and devices that change the trajectory of disease. My interests lie in regenerative medicine, biotechnology, and the challenge of translating research into impactful, scalable solutions.”
Medical student at Barts and The London with a research background in stem cells with a focus on the development of regenerative cell therapies.
Passionate about advancing biotechnologies to create disease-modifying therapeutics and medical devices.
Graduate of the Science Creates Engineering Biology accelerator, where she explored how to translate scientific research into commercially viable, venture-backable healthcare innovations.
“I’m driven by the ambition to turn cutting-edge science into real-world treatments—building new therapeutics and devices that change the trajectory of disease. My interests lie in regenerative medicine, biotechnology, and the challenge of translating research into impactful, scalable solutions.”
Rafe Tariq
Applied AI Venture Fellow
Rafe Tariq
Applied AI Venture Fellow
“I’m driven by solving the hardest deep science problems and real world impact from practical scientific discoveries. Currently I’m especially excited about Computational Life Science and Edge AI / Robotics, where intelligent systems have a growing impact on our day-to-day lives.”
PhD Artificial Intelligence / Genomics, University of Manchester.
Computer Science Master in Engineering, University of York.
“I’m driven by solving the hardest deep science problems and real world impact from practical scientific discoveries. Currently I’m especially excited about Computational Life Science and Edge AI / Robotics, where intelligent systems have a growing impact on our day-to-day lives.”
The LQD Venture Fellow Programme launches, with five scientists joining to enhance technical due diligence across the Fund’s five investment clusters.
May 2025
Fund I makes its maiden investment into Ignota Labs, pioneers of AI-driven drug rehabilitation.
May 2025
Ignota labs
LQD launches as a fully incorporated and regulated entity, completing its first close and contributing all previous investments into their inaugural fund.
April 2025
Oli Owens becomes LQD’s first official hire, joining from Green Angel Ventures to help uncover and evaluate new deep tech deals.
Jan 2025
The team invests in Cardiatec, who are developing novel cardiovascular treatments through their proprietary AI-driven multiomics discovery platform.
May 2024
As AI begins to impact the real world, LQD’s founders back Monumo, a breakout company revolutionising electric motor design and manufacturing.
November 2023
The team invests in Certo Aero and their unique UAV platform designed to save and protect lives.
October 2023
The founders make their first investment into Aegiq, backing a visionary team aiming to redefine the future of photonic quantum computing.
August 2023
Santiago, Andres and Andrew establish LQD, announcing it to the world on the summer solstice as a nod to the oldest science, astronomy.
June 2023